Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-191.19M
↓ 19% below average
Average (6y)
$-160.56M
Historical baseline
Range
High:$-23.78M
Low:$-299.51M
CAGR
+41.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-191.19M | +36.2% |
| 2023 | $-299.51M | -31.8% |
| 2022 | $-227.29M | -5.0% |
| 2021 | $-216.54M | -82.3% |
| 2020 | $-118.79M | -153.6% |
| 2019 | $-46.84M | -97.0% |
| 2018 | $-23.78M | - |